SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001679082-19-000009
Filing Date
2019-02-07
Accepted
2019-02-07 16:15:16
Documents
57
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q myovant10q12312018.htm 10-Q 1255717
2 EXHIBIT 10.6 exhibit106-employmentagree.htm EX-10.6 82668
3 EXHIBIT 31.1 myovantex31112312018.htm EX-31.1 10172
4 EXHIBIT 31.2 myovantex31212312018.htm EX-31.2 10290
5 EXHIBIT 32.1 myovantex32112312018.htm EX-32.1 6603
6 EXHIBIT 32.2 myovantex32212312018.htm EX-32.2 6267
  Complete submission text file 0001679082-19-000009.txt   4678841

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT myov-20181231.xml EX-101.INS 698012
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT myov-20181231.xsd EX-101.SCH 36998
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT myov-20181231_cal.xml EX-101.CAL 54542
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT myov-20181231_def.xml EX-101.DEF 205836
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT myov-20181231_lab.xml EX-101.LAB 473102
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT myov-20181231_pre.xml EX-101.PRE 288822
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS (441) 824-8101
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37929 | Film No.: 19575348
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences